Zoetis Inc. $ZTS Shares Sold by Fifth Third Bancorp

Fifth Third Bancorp decreased its holdings in Zoetis Inc. (NYSE:ZTS) by 20.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 112,370 shares of the company’s stock after selling 29,167 shares during the period. Fifth Third Bancorp’s holdings in Zoetis were worth $8,075,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Louisiana State Employees Retirement System acquired a new stake in Zoetis in the first quarter valued at $2,542,000. Deutsche Bank AG boosted its position in shares of Zoetis by 19.1% during the 4th quarter. Deutsche Bank AG now owns 5,558,183 shares of the company’s stock worth $699,331,000 after acquiring an additional 891,921 shares in the last quarter. Pincus Capital Management LP acquired a new position in shares of Zoetis during the 4th quarter worth about $2,109,000. Highbridge Capital Management LLC purchased a new position in shares of Zoetis in the 4th quarter valued at about $7,004,000. Finally, Pacer Advisors Inc. increased its holdings in shares of Zoetis by 16.7% in the 1st quarter. Pacer Advisors Inc. now owns 165,570 shares of the company’s stock valued at $19,572,000 after acquiring an additional 23,687 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Barclays decreased their target price on Zoetis from $136.00 to $85.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 1st. Zacks Research lowered shares of Zoetis from a “hold” rating to a “strong sell” rating in a research note on Monday, August 10th. BNP Paribas Exane cut their price objective on shares of Zoetis from $146.00 to $110.00 and set an “outperform” rating on the stock in a report on Tuesday, August 11th. HSBC reduced their price objective on shares of Zoetis from $140.00 to $95.00 and set a “buy” rating for the company in a research report on Monday, July 6th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Zoetis from $130.00 to $115.00 and set an “overweight” rating for the company in a report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $109.62.

Zoetis Trading Down 2.9%

Shares of Zoetis stock opened at $73.64 on Friday. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.84 and a current ratio of 3.08. The company has a market capitalization of $30.43 billion, a P/E ratio of 12.13, a PEG ratio of 1.28 and a beta of 0.74. Zoetis Inc. has a 1 year low of $71.45 and a 1 year high of $160.48. The company’s fifty day moving average is $76.30 and its two-hundred day moving average is $99.01.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, August 6th. The company reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.02. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The business had revenue of $2.47 billion during the quarter, compared to analysts’ expectations of $2.50 billion. During the same period in the prior year, the company earned $1.76 earnings per share. The business’s revenue was down .2% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. Analysts forecast that Zoetis Inc. will post 6.19 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.9%. Zoetis’s dividend payout ratio is currently 34.93%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.